Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy
2020 · Scientific Reports · 57 citations
https://doi.org/10.1038/s41598-020-71248-8
B
Benjamin Röben
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
208
Citations
7
h-index
6
i10-index
Benjamin Röben is an academic researcher from German Center for Neurodegenerative Diseases. The author has contributed to research in topics: Parkinson's Disease Mechanisms and Treatments & Dementia and Cognitive Impairment Research & Alzheimer's disease research and treatments. The author has an h-index of 7, co-authored 9 publications.
Papers by this author
worksNerve ultrasound characterizes AMN polyneuropathy as inhomogeneous and focal hypertrophic
2018 · Orphanet Journal of Rare Diseases · 14 citations
https://doi.org/10.1186/s13023-018-0939-7
Age-related deterioration of performance and increase of cortex activity comparing time- versus item-controlled fNIRS measurement
2021 · Scientific Reports · 8 citations
https://doi.org/10.1038/s41598-021-85762-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat